RGLS logo

Regulus Therapeutics (RGLS) Total Debt

Annual Total Debt

$2.39 M
-$3.89 M-61.95%

December 31, 2023


Summary


Performance

RGLS Total Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRGLSbalance sheetmetrics:

Quarterly Total Debt

$476.00 K
-$199.00 K-29.48%

September 30, 2024


Summary


Performance

RGLS Quarterly Total Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRGLSbalance sheetmetrics:

Total Debt Formula

Total Debt = Short Term Debt + Long Term Debt

RGLS Total Debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-62.0%-29.5%
3 y3 years-48.6%-92.7%
5 y5 years-85.6%-96.8%

RGLS Total Debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-66.3%at low-93.3%at low
5 y5-year-83.7%at low-96.8%at low
alltimeall time-89.8%-100.0%-98.0%-100.0%

Regulus Therapeutics Total Debt History

DateAnnualQuarterly
Sep 2024
-
$476.00 K(-29.5%)
Jun 2024
-
$675.00 K(-52.1%)
Mar 2024
-
$1.41 M(-41.1%)
Dec 2023
$2.39 M(-62.0%)
$2.39 M(-29.1%)
Sep 2023
-
$3.37 M(-22.4%)
Jun 2023
-
$4.34 M(-18.3%)
Mar 2023
-
$5.31 M(-15.4%)
Dec 2022
$6.28 M(-11.4%)
$6.28 M(-2.1%)
Sep 2022
-
$6.41 M(-2.0%)
Jun 2022
-
$6.55 M(-1.9%)
Mar 2022
-
$6.68 M(-5.8%)
Dec 2021
$7.09 M(+52.4%)
$7.09 M(-2.0%)
Sep 2021
-
$7.24 M(-2.0%)
Jun 2021
-
$7.38 M(-1.9%)
Mar 2021
-
$7.52 M(+61.7%)
Dec 2020
$4.65 M(-68.2%)
$4.65 M(-65.9%)
Sep 2020
-
$13.65 M(-6.8%)
Jun 2020
-
$14.64 M(+0.0%)
Mar 2020
-
$14.64 M(+0.0%)
Dec 2019
$14.63 M(-11.7%)
$14.63 M(+0.0%)
Sep 2019
-
$14.63 M(+0.0%)
Jun 2019
-
$14.62 M(-4.0%)
Mar 2019
-
$15.22 M(-8.1%)
Dec 2018
$16.57 M(-16.5%)
$16.57 M(-13.1%)
Sep 2018
-
$19.07 M(-4.1%)
Jun 2018
-
$19.89 M(+0.1%)
Mar 2018
-
$19.87 M(+0.1%)
DateAnnualQuarterly
Dec 2017
$19.86 M(+0.3%)
$19.86 M(+0.1%)
Sep 2017
-
$19.84 M(+0.1%)
Jun 2017
-
$19.83 M(+0.1%)
Mar 2017
-
$19.82 M(+0.1%)
Dec 2016
$19.80 M(>+9900.0%)
$19.80 M(+0.1%)
Sep 2016
-
$19.79 M(+0.0%)
Jun 2016
-
$19.79 M(>+9900.0%)
Mar 2016
-
$0.00(0.0%)
Dec 2015
$0.00(-100.0%)
$0.00(0.0%)
Sep 2015
-
$0.00(0.0%)
Jun 2015
-
$0.00(0.0%)
Mar 2015
-
$0.00(-100.0%)
Dec 2014
$23.40 M(+107.4%)
$23.40 M(+119.4%)
Sep 2014
-
$10.66 M(-14.3%)
Jun 2014
-
$12.45 M(-7.1%)
Mar 2014
-
$13.40 M(+18.8%)
Dec 2013
$11.28 M(+11.3%)
$11.28 M(-19.0%)
Sep 2013
-
$13.92 M(-4.6%)
Jun 2013
-
$14.59 M(+22.7%)
Mar 2013
-
$11.89 M(+17.4%)
Dec 2012
$10.13 M(+1.3%)
$10.13 M(-42.3%)
Sep 2012
-
$17.56 M(+213.6%)
Jun 2012
-
$5.60 M(>+9900.0%)
Mar 2012
-
$0.00(-100.0%)
Dec 2011
$10.00 M(>+9900.0%)
$10.38 M(>+9900.0%)
Sep 2011
-
$0.00
Dec 2010
$0.00
-

FAQ

  • What is Regulus Therapeutics annual total debt?
  • What is the all time high annual total debt for Regulus Therapeutics?
  • What is Regulus Therapeutics annual total debt year-on-year change?
  • What is Regulus Therapeutics quarterly total debt?
  • What is the all time high quarterly total debt for Regulus Therapeutics?
  • What is Regulus Therapeutics quarterly total debt year-on-year change?

What is Regulus Therapeutics annual total debt?

The current annual total debt of RGLS is $2.39 M

What is the all time high annual total debt for Regulus Therapeutics?

Regulus Therapeutics all-time high annual total debt is $23.40 M

What is Regulus Therapeutics annual total debt year-on-year change?

Over the past year, RGLS annual total debt has changed by -$3.89 M (-61.95%)

What is Regulus Therapeutics quarterly total debt?

The current quarterly total debt of RGLS is $476.00 K

What is the all time high quarterly total debt for Regulus Therapeutics?

Regulus Therapeutics all-time high quarterly total debt is $23.40 M

What is Regulus Therapeutics quarterly total debt year-on-year change?

Over the past year, RGLS quarterly total debt has changed by -$199.00 K (-29.48%)